Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
LFTHH Live Case - Clinical Utilisation Of Fractional Flow Reserve In MVD
Author(s): Justin E Davies Added: 9 years ago
Live Case from the Hammersmith Hospital, UK - Clinical Utilisation Of Fractional Flow Reserve (FFR) In Multi-Vessel Disease (MVD) AGENDA Introduction to the ethos of Live from the Hammersmith Outline for the live case broadcast Importance of FAME 3, Syntax in multi-vessel disease assessment in changing patient demographics Introduction of patient case FFR set up at the Hammersmith … View more

Intervention
View from the Thoraxcanter: ACC 22 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022. Trials covered in detail include: 00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients… View more

Anticoagulation

Vascular Disease and Surgery
Author(s): Colin Berry , Paul Knaapen , Keith G Oldroyd , et al Added: 6 years ago
A short series of 60-second insight videos on Multivessel Disease (MVD). View more

Prevention & Chronic Conditions
Author(s): Thomas Engstrøm Added: 3 years ago
Today, the interest in optimal treatment of acute coronary syndrome (ACS) has never been greater. Several factors have contributed to this including an expanding patient population, the poorer prognosis of patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease and the recent evidence from randomised trials suggesting that multivessel percutaneous coronary… View more

MI/ACS

Intervention
Ralph G Brindis
Research Area(s) / Expertise: Job title: Clinical Professor of Medicine
Dr Ralph Brindis, MD, MPH, MACC, FSCAI, FAHAis a Clinical Professor of Medicine at UCSF and holds affiliate faculty positions at the Phil R. Lee Institute of Health Policy Studies at UCSF. He currently serves as the Senior Medical Officer for External Affairs in the ACC National Cardiovascular Registry (ACC-NCDR). Dr Brindis was previously the President of the American College of Cardiology (ACC)… View more
Author(s): Jamie Layland Added: 3 years ago
Introduction Ischaemic heart disease, a major public health issue, is responsible for one in every six deaths and an estimated 1,065,000 will have an acute coronary syndrome (ACS) annually.1 ACS is an umbrella term that comprises unstable angina, non-ST segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).2 NSTEMI is the commonest form of acute… View more

Imaging & Diagnostics

MI/ACS
Author(s): Serban Balanescu Added: 3 years ago
Coronary artery disease (CAD) due to atherosclerosis is a major cause of morbidity and mortality. Early prevention of atherothrombotic disease with a healthy lifestyle (diet, exercise, optimal body weight and no smoking) is considered the best method of “treating” CAD, although increasing age remains associated with significant cardiovascular events. When coronary atherothrombotic disease… View more

Vascular Disease and Surgery

Imaging & Diagnostics
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more

Intervention
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 2 years ago
Learn about the key take-home messages from ACC.22 with View from the Thoraxcenter hosts, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL). In this succinct review video, they summarise the top late-breaking science trials and share their take on how the new data can be translated into practice. Trials covered in detail include: 00:29: PACMAN AMI:… View more

Anticoagulation

Vascular Disease and Surgery
Added: 3 years ago Source:  http://www.theneweconomy.com/technology/volcano-corporations-imaging-technologi…
Volcano Europe is the winner of the 2014 New Economy Award for Best Clinical Imaging Company. Egon Wülfert explains how breakthroughs could help reduce the number of deaths from the world’s biggest killer. Cardiovascular disease continues to be the world’s leading cause of death according to the World Health Organization. This has troubled the medical community andindustry for decades. In an… View more